PRECIGEN, INC. (PGEN)

↓ Download CSV

CIK 0001356090 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated VA
  • Fiscal year ends Dec 31

In fiscal 2025, PRECIGEN, INC. reported revenue of $9.68M, up 146.7% from the prior year. The company ran a net loss, with a net margin of -2588.2%. It held $155.50M in total assets against $134.59M in total liabilities.

Key ratios (FY2025)

-1141.1%
Operating margin
-2588.2%
Net margin
-1198.6%
Return on equity
+146.7%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$9.68M$3.92M$6.22M$26.91M$14.27M$31.99M$90.72M$151.18M$219.46M$190.93M
Cost of Revenue$33.26M$37.71M
Operating Income-$110.51M-$135.03M-$99.76M-$505.61M-$137.89M-$125.17M
Net Income-$250.64M-$126.23M-$95.90M$28.32M-$92.17M-$170.52M-$322.32M-$509.34M-$117.02M-$186.61M
EPS (Diluted)$-1.37$-0.47$-0.39$0.14$-0.47$-1.02$-2.09
Total Assets$155.50M$145.27M$151.04M$215.98M$359.86M$314.59M$455.76M$716.18M$846.85M$949.07M
Total Liabilities$134.59M$78.53M$32.55M$89.72M$252.51M$247.41M$384.05M$337.45M$300.31M$379.82M
Shareholders' Equity$20.91M$38.51M$118.50M$126.26M$107.35M$67.17M$71.71M$362.86M$533.63M$560.24M
Cash & Equivalents$30.23M$29.52M$7.58M$4.86M$36.42M$51.79M$65.79M$96.88M$68.11M$62.61M
Operating Cash Flow-$87.83M-$68.17M-$66.93M-$65.05M-$55.77M-$77.02M-$135.93M-$124.24M-$103.72M-$48.99M
Capital Expenditures$2.00M$8.58M$1.54M$4.92M$7.25M$7.53M$37.88M$41.59M$46.67M$31.63M
Shares Outstanding353.91M292.87M248.92M208.15M206.74M187.66M163.27M160.02M122.09M118.69M